Millions Refused the CPAP Mask. This Sleep Apnea Pill Just Entered FDA Review.
The FDA has accepted for review Oxnimbi (AD109), a once-nightly pill for sleep apnea patients who refused CPAP. In a Phase 3 trial of 646 patients, it cut breathing interruptions by 44

Follow